Overview
Dr. DeVore is a cardiologist and Associate Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include caring for patients and families with heart failure, including those with left ventricular assist devices and heart transplants. He is involved in and leads multiple large studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute. He currently serves as the medical director of the Duke Heart Transplant program.
He attended medical school at the University of Chicago Pritzker School of Medicine and completed internal medicine residency at Brigham and Women’s Hospital. He then pursued cardiology training at Duke University and solidified his interests in clinical research and heart failure. He completed a research fellowship at the Duke Clinical Research Institute and a Masters of Health Sciences in Clinical Research before completing an advanced heart failure fellowship at Duke University.
The overarching goals of his research are to advance the current understanding of heart failure through clinical trials as well as develop an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. For example, he has served on the Steering Committees for large clinical trials, including PIONEER-HF and SPIRRIT-HFpEF. Dr. DeVore also published the first clinical trial conducted within the American Heart Association’s Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He was also the principal investigator for CONNECT-HF, a large-scale, pragmatic, cluster-randomized trial at 161 sites in the US evaluating heart failure quality improvement initiatives. Outside of his work on heart failure, Dr. DeVore is married with 4 children and spends his time corralling them all and coaching youth baseball.
Current Appointments & Affiliations
Recent Publications
Finerenone for Prevention of First-Detected AF Across the Cardio-Kidney-Metabolic Spectrum: Insights From the FINE-HEART Pooled Analysis
Journal Article Journal of the American College of Cardiology · May 6, 2025 Full text CiteSurveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events: Results From SCALE-HF 1.
Journal Article J Card Fail · April 2025 BACKGROUND: There is a need for better noninvasive remote monitoring solutions that prevent hospitalizations through the early prediction and management of heart failure (HF). SurveillanCe and Alert-Based Multiparameter Monitoring to ReducE Worsening Heart ... Full text Link to item CiteUtilization and Outcomes of Ex Vivo Heart Perfusion in Donation After Brain Death Heart Transplantation.
Journal Article JACC Heart Fail · April 1, 2025 Full text Link to item CiteRecent Grants
Merck - CHA - Guidelines Implementation Study - Industry
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme LLC. · 2025 - 2027A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance with Cell-free DNA versus Endomyocardial Biopsy (ACES-EMB)
Clinical TrialPrincipal Investigator · Awarded by Natera, Inc · 2024 - 2027Elevate-HF
Clinical TrialPrincipal Investigator · Awarded by Ventricle Health, Inc. · 2024 - 2026View All Grants